A common medication may have an unexpected effect on a serious eye condition, new research suggests.

Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and ...

Retatrutide, a possible advance on GLP-1 drugs like Zepbound, significantly cut blood sugar and body weight in the study, a sign it might be similarly impactful against obesity.

SELECT was a large study focused on obesity and cardiovascular disease in people without type 2 diabetes, but it included kidney outcomes as a secondary end point. The data showed that semaglutide ...

Metformin use in people with diabetes was linked to a significantly lower risk of developing intermediate age-related macular degeneration.

Drugs such as semaglutide may be useful for mental health conditions associated with diabetes, authors say ...

GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness ...

From online forums to the clinic, people have reported that diabetes and weight-loss drugs such as Ozempic and Wegovy can ...

Clinical and payer strategies should treat GLP‑1 therapy as chronic for high-risk patients, addressing tolerability and cost ...

The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification.

Living with diabetes doesn’t have to mean accepting a lifetime of increasing medication doses and constant worry about blood sugar spikes. While traditional medical approaches focus heavily on ...

The research analysed data from more than 750,000 pregnancies, making it one of the largest studies to examine this issue so far.